PPARG and metabolic dysfunction-associated steatotic liver disease: For NAFLD, several studies have evaluated whether the differential DNA methylation at the peroxisome proliferator-activated receptor Gamma (PPARγ) promoter can be detected within the pool of cell-free DNA of human plasma to avoid taking a biopsy.